Seizures and Epilepsy in Patients With Untreated Cerebral Cavernous Malformations
Neurology® Podcast
Dr. Halley Alexander talks with Dr. Abel Sandmann about seizure rates and risk factors in patients with cerebral cavernous malformations (CCMs) during long-term follow-up without CCM intervention. Read the related article in . Disclosures can be found at .
info_outline
Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines
Neurology® Podcast
Dr. Tesha Monteith talks with Dr. Jennifer Robblee about the latest consensus on refractory migraine, its definition, and management strategies, including new guidelines for emergency treatment. Read the related article in . Read the related article in . Disclosures can be found at .
info_outline
The Best of Headache Medicine from 2025: A Year in Review
Neurology® Podcast
Dr. Tesha Monteith talks with Dr. Patricia Pozo-Rosich about the latest advancements in headache medicine, focusing on key research findings from 2025. Disclosures can be found at .
info_outline
Overview from the 2026 International Stroke Conference
Neurology® Podcast
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about the latest findings from the 2026 International Stroke Conference. Read more about the . Read more about the . Read more about the . Disclosures can be found at .
info_outline
March 2026 Recall: Topics in Hospital Neurology
Neurology® Podcast
The March 2026 recall showcases four previously posted episodes focused on clinical issues relevant to hospital-based neurologists. The episode opens with Dr. Jennifer E. Fugate discussing PRES, focusing on clinical presentation, diagnostic criteria, neuroimaging findings, and management strategies. The episode continues with Dr. Ava Easton discussing the World Health Organization's technical brief on encephalitis. In the third episode, Dr. Matthew Ryan Woodward discusses the complexities of status epilepticus, from definition through refractory and super-refractory stages. The episode...
info_outline
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
Neurology® Podcast
Dr. Andy Southerland talks with Dr. Shyam Prabhakaran about the 2026 AHA/ASA guidelines for the early management of acute ischemic stroke, highlighting key recommendations, the role of advanced imaging, and the importance of thrombolysis and thrombectomy. Read the related article in the journal Disclosures can be found at .
info_outline
Consensus Recommendations for Diagnosis and Management of Vanishing White Matter
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Marjo S. van der Knaap and Romy J. van Voorst about expert consensus recommendations for the diagnosis and management of vanishing white matter and the importance of standardizing care worldwide. Read the related article in . Disclosures can be found at .
info_outline
Clinical Insights Into CASPR1 and CASPR1/Contactin-1 Complex Autoimmune Nodopathies
Neurology® Podcast
Dr. Alex Menze talks with Dr. Divyanshu Dubey about the clinical insights into autoimmune nodopathies, particularly focusing on CASPR1 and CASPR1/CNTN1-complex-IgG. Read the related article in . Disclosures can be found at .
info_outline
Diagnostic Yield of Reanalysis After Nondiagnostic Genome Sequencing in Infants With Unexplained Epilepsy
Neurology® Podcast
Dr. Halley Alexander talks with Dr. Alissa M. D'Gama about genetic testing for infantile epilepsies. Read the related article in. Disclosures can be found at .
info_outline
CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers
Neurology® Podcast
Dr. Greg Cooper talks with Dr. David G. Coughlin about the role of αSyn-SAAs in diagnosing dementia with Lewy bodies and their relationship with Alzheimer disease biomarkers. Read the related article in . Disclosures can be found at .
info_outlineThe December 2023 replay wraps up the year with four previously posted episodes on neurocritical care. The episode begins with an interview with Dr. Karin Diserens on subtle clinical signs in unresponsive brain-impaired individuals. The episode continues with an interview with Dr. David Greer on updated brain death guidelines. The next interview is with Dr. Monica Lemmon on communicating information about neurologic prognosis. The fourth and final interview is with Drs. Susanne Muehlschlegel and Adeline Goss on the prognostic language used in critical neurologic illness.
Related Podcast Links:
Subtle Clinical Signs in Unresponsive Brain Impairment: https://directory.libsyn.com/episode/index/id/27124839
Updated Pediatric and Adult BD/DNC Consensus Guidelines: https://directory.libsyn.com/episode/index/id/28537073
A Parent-Informed Approach to Communicating Neurologic Prognosis in Infants: https://directory.libsyn.com/episode/index/id/25988781
Language Use in Neurocritical Illness Prognostication: https://directory.libsyn.com/episode/index/id/28137575
Related Article Links:
A Focus on Subtle Signs and Motor Behavior to Unveil Awareness in Unresponsive Brain-Impaired Patients: The Importance of Being Clinical: https://doi.org/10.1212/WNL.0000000000207067
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM: https://doi.org/10.1212/WNL.0000000000207740
The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions: https://doi.org/10.1212/WNL.0000000000201600
Prognostic Language in Critical Neurologic Illness: A Multicenter Mixed-Methods Study: https://doi.org/10.1212/WNL.0000000000207462
Disclosures can be found at Neurology.org